Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN270557 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Glucagon-Like Peptide 1 Receptor (GLP1R) (AA 100-200), (Extracellular), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 100-200, Extracellular, N-Term
- Vial size
- 0.05 mL
- Storage
- Store at 4°C short term. Aliquot and store at -80°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Decreased glucagon-like peptide 1 receptor expression in endothelial and smooth muscle cells in diabetic db/db mice: TCF7L2 is a possible regulator of the vascular glucagon-like peptide 1 receptor.
Immunohistochemical, apoptotic and biochemical changes by dipeptidyl peptidase-4 inhibitor-sitagliptin in type-2 diabetic rats.
Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.
Kimura T, Obata A, Shimoda M, Okauchi S, Hirukawa H, Kohara K, Kinoshita T, Nogami Y, Nakanishi S, Mune T, Kaku K, Kaneto H
Diabetes & vascular disease research 2017 Nov;14(6):540-548
Diabetes & vascular disease research 2017 Nov;14(6):540-548
Immunohistochemical, apoptotic and biochemical changes by dipeptidyl peptidase-4 inhibitor-sitagliptin in type-2 diabetic rats.
Karabulut S, Coskun ZM, Bolkent S
Pharmacological reports : PR 2015 Oct;67(5):846-53
Pharmacological reports : PR 2015 Oct;67(5):846-53
Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin.
Matveyenko AV, Dry S, Cox HI, Moshtaghian A, Gurlo T, Galasso R, Butler AE, Butler PC
Diabetes 2009 Jul;58(7):1604-15
Diabetes 2009 Jul;58(7):1604-15
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC